QNCX
Quince Therapeutics, Inc.
33.00$
+4.2%
vs. previous close
Closing price · As of: Oct 30, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Quince Therapeutics, Inc. (QNCX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 10/21/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 10/19/2026 | Current report (8-K) | IRulya Therapeutics Inc. (QNCX): Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 10/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 10/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 10/09/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report ↗ |
| 10/06/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View report ↗ |
| 10/02/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 09/14/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Completion of Acquisition or Disposition of Assets; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits | View report ↗ |
| 09/04/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | View report ↗ |
| 08/27/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 08/17/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/04/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/31/2026 | Current report (8-K) | Quince Therapeutics, Inc. (QNCX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.